Abstract:Objective: To detect the expression of GPR160 receptors in the spinal cord of rats with bone cancer pain, and to investigate the role of GPR160 receptors in the development of bone cancer pain. Methods: Ninety-one female SD rats were randomly divided into five groups: Naive group (n=11), Sham group (n=28), BCP group (n=36), BCP + GPR160-siRNA group (BCP+siGpr160, n=8), BCP+ control siRNA group (BCP+ sieGfp, n=8). Paw withdrawal threshold (PWT) was assessed with von Frey. Rats gaits were evaluated with Catwalk gait analysis. Western blotting was used to detect the expression of GPR160 protein in spinal cord. Real-time PCR was used to detect the mRNA of GPR160 in spinal cord. The protein of TNF-α, IL-1β and IL-6 was detected with ELISA and Western Blot. Results: PWT was significantly decreased 6 days after BCP and lasted until 18 days (P <0.001). There was obvious infiltration of cancer cells and bone destruction 18 days after BCP. Compared with control group, the expression of GPR160 and pro-inflammatory cytokines TNF-α, IL-1β and IL-6 in BCP group was significantly increased. However, intrathecal injection of GPR160-siRNA remarkably attenuated the expression of it compared with BCP+sieGfp group. Conclusion: These results suggest that GPR160 receptors could be involved in central sensitization, and the mechanism may be related to the increased expression of pro-inflammatory cytokines.